FindTrial
Sign In

Prevalence of asymptomatic COVID positivity in the pre-operative patient

Incidence of SARS-CoV2 infection among ASymptomaticpatients undergoing PrE-operative COVID Testing prior to cancer surgery - ASPECT study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032965
Enrollment
2200
Registered
2021-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who underwent preoperative SARS-C0V-2 testing prior to cancer surgery (elective and emergency)

Exclusion criteria

Exclusion criteria: symptomatic patients who planned to underwent preoperative SARS-C0V-2 testing prior to cancer surgery

Design outcomes

Primary

MeasureTime frame
Percentage of asymptomatic infection among those patients undergoing routine preoperative testing before cancer surgery using RT-PCR of nasopharyngeal and oropharyngeal swabsTimepoint: 7 months—

Secondary

MeasureTime frame
-Intent and treatment received subsequently among those who tested positive. -Treatment completion rates, including adjuvant treatment. -Complication rates amongst patients who tested positive for SARS Cov2 infection -Proportion of patients who tested positive within 30 days after surgery after a negative preoperative test Timepoint: 7 months—

Countries

India

Contacts

Public ContactShraddha Patkar

Tata Memorial Centre

drshraddhapatkar@gmail.com9820074818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026